21
Views
0
CrossRef citations to date
0
Altmetric
Articles

In-vitro and in-vivo Anti-Hyperglycemic Potential of Prosopis cineraria Pods Extract and Fractions

, &
Pages 135-140 | Received 29 Dec 2018, Accepted 27 Feb 2019, Published online: 30 Apr 2019
 

Abstract

Prosopis cineraria (L.) Druce pods are commonly used as vegetable and it is reported to possess anti-diabetic potential. This study aims to establish α-glucosidase inhibitory potential in-vitro and in-vivo. The shade dried pods were extracted and lyophilized extract was fractionated using solvents of different polarity. These fractions were evaluated for their potential to inhibit enzymes α-glucosidase and α-amylase, in-vitro. The most potent fraction was subjected to oral toxicity study followed by in-vivo sucrose tolerance test. The ethyl acetate fraction was found to be a most potent inhibitor of α-glucosidase with IC50 of 8.38 ± 0.26 μg/ml while n-butanol fraction was the most potent inhibitor of the enzyme α-amylase (IC50 22.01 ± 0.92 μg/ml). Both fractions were found to be nontoxic and safe in mice up to an oral dose of 2000 mg/kg. Ethyl acetate fraction was found to most potent fraction in-vivo. Ethyl acetate fraction displayed excellent anti-hyperglycaemic activity in-vitro and in-vivo and should be evaluated further to develop as a promising drug for management of diabetes mellitus.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.